ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $507,279 | -14.5% | 18,879 | +13.5% | 0.00% | – |
| Q2 2023 | $593,311 | +59.5% | 16,638 | +13.6% | 0.00% | – |
| Q1 2023 | $372,059 | -36.5% | 14,648 | +1.5% | 0.00% | -100.0% |
| Q4 2022 | $585,524 | +42.1% | 14,436 | +15.8% | 0.00% | – |
| Q3 2022 | $412,000 | -8.2% | 12,467 | -2.3% | 0.00% | – |
| Q2 2022 | $449,000 | -38.1% | 12,755 | -19.1% | 0.00% | -100.0% |
| Q1 2022 | $725,000 | -40.0% | 15,766 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $1,209,000 | +1.3% | 18,236 | -4.6% | 0.00% | 0.0% |
| Q3 2021 | $1,193,000 | +51.0% | 19,116 | +100.4% | 0.00% | 0.0% |
| Q2 2021 | $790,000 | +38.8% | 9,537 | +11.2% | 0.00% | 0.0% |
| Q1 2021 | $569,000 | -16.6% | 8,578 | -3.5% | 0.00% | 0.0% |
| Q4 2020 | $682,000 | +38.3% | 8,893 | -22.3% | 0.00% | 0.0% |
| Q3 2020 | $493,000 | -12.0% | 11,451 | -11.7% | 0.00% | 0.0% |
| Q2 2020 | $560,000 | +64.7% | 12,963 | +9.7% | 0.00% | 0.0% |
| Q1 2020 | $340,000 | -59.6% | 11,820 | -11.0% | 0.00% | -50.0% |
| Q4 2019 | $842,000 | +242.3% | 13,275 | +52.1% | 0.00% | +100.0% |
| Q3 2019 | $246,000 | +89.2% | 8,726 | -16.6% | 0.00% | – |
| Q4 2018 | $130,000 | +465.2% | 10,469 | -17.8% | 0.00% | – |
| Q1 2017 | $23,000 | +9.5% | 12,733 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | -62.5% | 12,733 | +24.4% | 0.00% | – |
| Q2 2016 | $56,000 | – | 10,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |